BRPI0417793A - bifidobactéria globosum probiótica canina - Google Patents

bifidobactéria globosum probiótica canina

Info

Publication number
BRPI0417793A
BRPI0417793A BRPI0417793-2A BRPI0417793A BRPI0417793A BR PI0417793 A BRPI0417793 A BR PI0417793A BR PI0417793 A BRPI0417793 A BR PI0417793A BR PI0417793 A BRPI0417793 A BR PI0417793A
Authority
BR
Brazil
Prior art keywords
globosum
bifidobacteria
probiotic bifidobacterium
bifidobacterium globosum
present
Prior art date
Application number
BRPI0417793-2A
Other languages
English (en)
Inventor
Thomas William-Maxwell Boileau
Michael Anthony Ceddia
John Kevin Collins
Gary Mitchell Davenport
Barry Pius Kiely
Liam Diarmuid O'mahony
Gregory Dean Sunvold
Mark Alan Tetrick
Robert Jason Vickers
Original Assignee
Iams Company
Alimentary Health Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Iams Company, Alimentary Health Ltd filed Critical Iams Company
Publication of BRPI0417793A publication Critical patent/BRPI0417793A/pt
Publication of BRPI0417793B1 publication Critical patent/BRPI0417793B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A23K50/42—Dry feed
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A23K50/45—Semi-moist feed
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A23K50/48—Moist feed
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Animal Husbandry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Physiology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nutrition Science (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

"BIFIDOBACTéRIA GLOBOSUM PROBIóTICA CANINA". De acordo com a presente invenção, é apresentada uma cepa de bactérias formadoras de ácido láctico da espécie bifidobacteria globosum, obtenível mediante isolamento a partir de trato gastrointestinal canino ressecado e lavado, e apresentando uma atividade probiótica em animais. São apresentados, também, métodos de uso e composições compreendendo as Bifidobacteria globosum da presente invenção.
BRPI0417793A 2003-12-19 2004-12-17 composição compreendendo bifidobactéria globosum probiótica canina BRPI0417793B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53158803P 2003-12-19 2003-12-19
PCT/US2004/043071 WO2005062878A2 (en) 2003-12-19 2004-12-17 Canine probiotic bifidobacteria globosum

Publications (2)

Publication Number Publication Date
BRPI0417793A true BRPI0417793A (pt) 2007-04-10
BRPI0417793B1 BRPI0417793B1 (pt) 2016-05-10

Family

ID=34738669

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0417793A BRPI0417793B1 (pt) 2003-12-19 2004-12-17 composição compreendendo bifidobactéria globosum probiótica canina

Country Status (9)

Country Link
US (4) US20050152884A1 (pt)
EP (1) EP1718265B1 (pt)
JP (1) JP4607124B2 (pt)
AR (1) AR047294A1 (pt)
AU (1) AU2004308395B2 (pt)
BR (1) BRPI0417793B1 (pt)
CA (1) CA2550307C (pt)
ES (1) ES2388739T3 (pt)
WO (1) WO2005062878A2 (pt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060116330A1 (en) * 1997-07-08 2006-06-01 The Iams Company Methods of mimicking the metabolic effects of caloric restriction by administration of mannoheptulose
US8563522B2 (en) * 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
US20020035071A1 (en) * 1997-07-08 2002-03-21 Josef Pitha Mimicking the metabolic effects of caloric restriction by administration of glucose antimetabolites
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US20050152884A1 (en) 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US20050158294A1 (en) * 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US8894991B2 (en) * 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
AU2006253006B8 (en) * 2005-05-31 2011-09-15 Alimentary Health Ltd Feline probiotic Lactobacilli
JP4938006B2 (ja) * 2005-05-31 2012-05-23 ザ・アイムス・カンパニー ネコ科動物プロバイオティク・ビフィドバクテリア
CN101257910B (zh) * 2005-09-08 2012-05-23 株式会社益力多本社 胆固醇吸收抑制剂
US7682619B2 (en) * 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
EP2124966B1 (en) 2007-02-01 2015-09-09 IAMS Europe B.V. Method for decreasing inflammation and stress in a mammal using glucose antimetabolites, avocado or avocado extracts
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
EP2334196B1 (en) * 2008-09-11 2012-08-29 The IAMS Company Animal feed kibble with protein-based core and related methods
US20100112143A1 (en) * 2008-11-03 2010-05-06 Liberatore Nekae Animal Food and Packaging Therefor
EP3120709A1 (en) 2009-05-28 2017-01-25 IAMS Europe B.V. Pet food in the form of a coated kibble
US8691303B2 (en) * 2009-07-31 2014-04-08 The Iams Company Dusted animal food
US9210945B2 (en) 2009-07-31 2015-12-15 The Iams Company Animal food having low water activity
US20110027417A1 (en) * 2009-07-31 2011-02-03 Patrick Joseph Corrigan Process for Dusting Animal Food
US9173423B2 (en) 2009-07-31 2015-11-03 The Iams Company Animal food kibble with electrostatically adhered dusting
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
EP2506764B1 (en) * 2010-01-06 2017-03-15 Hill's Pet Nutrition, Inc. Method of managing a weight condition in an animal
CN102711512A (zh) 2010-01-22 2012-10-03 爱默思公司 用于制备涂覆的粗磨食物形式的宠物食品的方法
WO2012027519A2 (en) 2010-08-27 2012-03-01 The Iams Company Methods of measuring activities of daily living
WO2012100269A1 (en) * 2011-01-23 2012-07-26 Glanbia Nutritionals (Ireland) Ltd. Pet food composition
US20130295227A1 (en) 2012-05-01 2013-11-07 Robbert H. ter Haar Composition Comprising a Sensitive Ingredient
EP3258792A1 (en) 2015-02-16 2017-12-27 Mars, Incorporated Interlocking kibble
CA2982836A1 (en) 2015-04-28 2016-11-03 Mars, Incorporated Process of preparing a sterilized wet pet food product

Family Cites Families (135)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2540979A (en) * 1948-04-24 1951-02-06 Smith Kline French Lab Enteric coating
BE634858A (pt) * 1962-07-19 1900-01-01
DE1204363B (de) * 1963-09-10 1965-11-04 Hoffmann La Roche Verfahren zur Herstellung einer oralen Arzneizubereitung, die ihren Wirkstoff erst im Ileum abgibt
GB1190387A (en) 1966-05-24 1970-05-06 Green Cross Corp Enteric Coated Medicaments
US3677898A (en) * 1969-01-31 1972-07-18 Ajinomoto Kk Acid protease and method of preparing the same
US3898132A (en) * 1972-08-24 1975-08-05 Int Feed Improvement Ass Inc Method of preparing stowable, dormant bacteria
US3957974A (en) * 1974-11-05 1976-05-18 Seikenkai Method for deodorization of excrements
JPS6038372B2 (ja) 1975-04-09 1985-08-31 日清製粉株式会社 犬の下痢予防および治療方法
JPS52102419A (en) * 1976-02-23 1977-08-27 Seikenkai Lactic acid producing bacillus preparation
GB1595054A (en) 1977-11-14 1981-08-05 Metal Box Co Ltd Capsules containing micro-organisms
CH637297A5 (fr) * 1978-12-05 1983-07-29 Nestle Sa Microbille comprenant un microorganisme et son procede de fabrication.
US4338346A (en) * 1978-12-21 1982-07-06 The Procter & Gamble Company Non-nutritive sweetener
FR2453215A1 (fr) * 1979-04-05 1980-10-31 Rhone Poulenc Ind Procede d'inclusion de micro-organismes dans une matrice de polymere
US4248857A (en) * 1979-08-09 1981-02-03 American Home Products Corporation Sustained release pharmaceutical compositions
US4411925A (en) * 1980-01-21 1983-10-25 Pfizer Inc. Branched amides of L-aspartyl-d-amino acid dipeptides
US4399163A (en) * 1980-11-05 1983-08-16 Pfizer Inc. Branched amides of L-aspartyl-D-amino acid dipeptides
US4423029A (en) * 1981-06-25 1983-12-27 The Procter & Gamble Company (S)-3-Amino-4-[(S,S)-1-(1-hydroxyethyl)alkyl amino]-4-oxo-butyric acid compounds suitable as non-nutritive sweetners
NL8203297A (nl) 1982-08-24 1984-03-16 Philips Nv Weerstandslichaam.
US4518696A (en) * 1983-01-11 1985-05-21 Chr. Hansen's Laboratory, Inc. Stabilized liquid bacterial suspension for oral administration to animals
US4592748A (en) * 1984-05-18 1986-06-03 Vortex Research Corp. Yoghurt based douche kit and assembly therefor
CA1276394C (en) 1984-07-13 1990-11-13 John M. Janusz Alpha-l-aspartyl-d-phenylglycine esters and amides useful as high intensity sweeteners
SE463598B (sv) * 1984-11-08 1990-12-17 Chemical Dynamics Sweden Ab Preparat, avsett att oeka vidhaeftningen av bakterier till mag-tarmkanalen hos maenniskor och djur, samt ett framstaellningsfoerfarande foer detta
DE3678644D1 (de) 1985-08-16 1991-05-16 Procter & Gamble Wirkstoffpartikel mit sowohl kontinuierlicher als auch schneller freisetzung.
EP0212746B1 (en) 1985-08-16 1991-04-10 The Procter & Gamble Company Drug particles having constant release
JPS62201823A (ja) 1986-02-28 1987-09-05 Freunt Ind Co Ltd 腸内有用細菌含有物およびその製造方法
US5160745A (en) * 1986-05-16 1992-11-03 The University Of Kentucky Research Foundation Biodegradable microspheres as a carrier for macromolecules
JPH041402Y2 (pt) 1986-06-16 1992-01-17
CA1300538C (en) 1986-08-01 1992-05-12 Robert Charley Maintenance of the viability of microorganisms for use in microbial inoculants
US4781939A (en) * 1986-10-28 1988-11-01 Nestec, S.A. Layered meat emulsion product and method of producing same
US4816259A (en) * 1987-02-12 1989-03-28 Chase Chemical Company, L.P. Process for coating gelatin capsules
US4797289A (en) * 1987-03-09 1989-01-10 Reddy Malireddy S Enhancement of lactobacillus acidophilus growth and viability in yogurt and other cultured dairy products
DE3856591D1 (de) 1987-05-01 2006-08-24 Biogaia Biolog Ab Reuterin enthaltende Nährungszusammensetzung
US5413960A (en) * 1987-05-01 1995-05-09 Biogaia Ab Antibiotic reuterin
FI77573C (fi) * 1987-05-08 1989-04-10 Orion Yhtymae Oy Ny konsistens.
FR2615203B1 (fr) 1987-05-12 1989-08-18 Agronomique Inst Nat Rech Inoculum dans lequel les micro-organismes sont conditionnes sous la forme de granules biodegradables, son procede de preparation et ses applications
GB8713601D0 (en) 1987-06-10 1987-07-15 Unilever Plc Fermentation
US4859377A (en) * 1987-07-10 1989-08-22 The United States Of America, As Represented By The Secretary Of Agriculture Starch encapsulation of entomopathogens
US4806368A (en) * 1987-09-16 1989-02-21 Reddy Malireddy S Shelf life and subsequent growth of lactobacillus acidophilus, propionibacterium shermanii and leuconostoc citrovorum in dietary fiber based supplement preparation
DK686187D0 (da) 1987-12-23 1987-12-23 Hansens Chr Bio Syst Veterinaert praeparat
JPH01278781A (ja) 1988-05-02 1989-11-09 Nec Corp 不揮発性半導体記憶装置
CA1333564C (en) 1988-08-02 1994-12-20 Thomas Julius Borody Treatment of gastro-intestinal disorders
IT1227154B (it) 1988-08-05 1991-03-19 A Tosi Farmaceutici S R L Nova Composizioni farmaceutiche per uso ginecologico a base di lattobacilli
IT1230576B (it) 1988-10-20 1991-10-28 Angeli Inst Spa Formulazioni farmaceutiche per via orale a liberazione selettiva nel colon
AU5254790A (en) 1989-04-06 1990-10-11 Chugai Seiyaku Kabushiki Kaisha Process for preparing a therapeutic agent for rotavirus infection
US5540945A (en) * 1989-05-11 1996-07-30 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical preparations for oral administration that are adapted to release the drug at appropriate sites in the intestines
PT94108A (pt) 1989-05-24 1991-02-08 Asahi Chemical Ind Preparacao de microorganismos viaveis contendo esporos estabilizada,sua producao e pilulas respectivas
JPH06101994B2 (ja) 1989-08-16 1994-12-14 ユニコロイド株式会社 耐消化性腸内有用細菌及びその製法
PH27186A (en) * 1989-09-07 1993-04-16 Ciba Geigy Ag Double-coated granules of disodium pamidronate
DE3933528C1 (pt) * 1989-10-04 1990-12-06 Effem Gmbh, 2810 Verden, De
SE465206B (sv) * 1989-12-22 1991-08-12 Eva Grahn Farmaceutisk beredning foer bekaempning av patogena tarmbakterier
US5198227A (en) 1990-01-22 1993-03-30 Mcneil-Ppc, Inc. Dual subcoated simulated capsule medicament
DK203090A (da) 1990-02-28 1991-08-29 Sitia Yomo Spa Maelkeagtig mousse, dens tilberedning og anvendelse
FI88856C (fi) 1990-05-18 1997-07-01 Alko Yhtioet Oy Foerfarande foer framstaellning av ett fermenterat, huvudsakligen pao havrekli baserat, levande mikroorganismer innehaollande livsmedel
IE61651B1 (en) * 1990-07-04 1994-11-16 Zambon Spa Programmed release oral solid pharmaceutical dosage form
FR2668081B1 (fr) 1990-10-19 1994-11-18 Lvmh Rech Procede et appareil de fabrication de particules solides a partir d'un materiau solidifiable en presence d'un agent de solidification en de bons rendements.
IT1244691B (it) 1991-01-29 1994-08-08 Sitia Yomo Spa Mousse lattea, suo impiego per preparare dessert e dessert cosi' ottenuti
GB9107305D0 (en) 1991-04-08 1991-05-22 Unilever Plc Probiotic
FR2678166B1 (fr) * 1991-06-27 1993-10-22 Bioeurope Compositions cosmetiques contenant des glucooligosaccharides.
WO1993002558A1 (en) 1991-08-01 1993-02-18 Biogaia Biologics Ab Method and formulation for reducing microbial populations
US5286495A (en) * 1992-05-11 1994-02-15 University Of Florida Process for microencapsulating cells
DK0671933T3 (da) 1992-08-20 1998-09-23 Schering Corp Hidtil ukendte anvendelser af IL-10
US5403799A (en) * 1992-12-21 1995-04-04 W. R. Grace & Co.-Conn. Process upset-resistant inorganic supports for bioremediation
JP3472317B2 (ja) 1993-02-26 2003-12-02 味の素ファルマ株式会社 被覆製剤
EP0706400A1 (en) 1993-03-15 1996-04-17 Pharma Pacific Pty. Ltd. Therapeutic formulation and method
IT1265092B1 (it) 1993-05-31 1996-10-30 Giuliani Spa Preparato per uso come integratore alimentare, o dietetico,a rilascio mirato nel colon
GB9318439D0 (en) 1993-09-06 1993-10-20 Zeneca Ltd Probiotics
US5733568A (en) 1993-12-03 1998-03-31 Lafor Laboratories Limited Micro-encapsulated lactobacilli for medical applications
JP3559790B2 (ja) 1993-12-20 2004-09-02 松谷化学工業株式会社 食品にビフィズス菌の増殖促進作用を付与する方法
US5486507A (en) * 1994-01-14 1996-01-23 Fuisz Technologies Ltd. Porous particle aggregate and method therefor
IT1270216B (it) 1994-06-14 1997-04-29 Recordati Chem Pharm Metodo di stabilizzazione di composti biologicamente attivi mediante microgranuli ricoperti sospendibili in fluidi alimentari
GB2290965A (en) 1994-07-11 1996-01-17 Therapicon Srl Multiple layer capsules for drugs
US5849327A (en) * 1994-07-29 1998-12-15 Advanced Polymer Systems, Inc. Delivery of drugs to the lower gastrointestinal tract
US5531988A (en) * 1994-10-28 1996-07-02 Metagenics, Inc. Bacteria and immunoglobulin-containing composition for human gastrointestinal health
US5569017A (en) * 1994-12-22 1996-10-29 Ametek, Inc. Fan end bracket for high velocity low pressure blowers
US5733540A (en) * 1995-03-08 1998-03-31 Lee; Peter Poon-Hang Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria
JPH08242763A (ja) 1995-03-10 1996-09-24 Morishita Jintan Kk カプセル化された腸内有用細菌を含有するヨーグルト
CR5278A (es) * 1995-03-24 1996-07-04 Lilly Co Eli Formulacion oral de 2-metil-tieno-benzodiacepina
IT1276783B1 (it) * 1995-06-23 1997-11-03 Bracco Spa Formulazioni farmaceutiche e dietetiche per la profilassi e la cura di affezioni gastrointestinali
US5785990A (en) * 1995-07-10 1998-07-28 Merrick's, Inc. Feed fortifier and enhancer for preruminant calves and method of using same
SG80553A1 (en) * 1995-07-20 2001-05-22 Tanabe Seiyaku Co Pharmaceutical preparation in form of coated capsule releasable at lower part of digestive tract
FI102298B1 (fi) 1995-09-07 1998-11-13 Oulutech Oy Menetelmä maitohappobakteerilajien määrittämiseksi ja menetelmään soveltuvia oligonukleotideja
US5702679A (en) 1995-10-06 1997-12-30 Kerr-Mcgee Chemical Corp. Method of preparing Li1+X- Mn2-X O4 for use as secondary battery
US6506389B2 (en) * 1995-10-20 2003-01-14 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek (Tno) Adherence factors of non pathogenic microorganisms and applications thereof for screening microorganisms for specific probiotic properties; novel pharmaceutical compositions and food additives comprising such microorganisms and adherence factors
US5853697A (en) * 1995-10-25 1998-12-29 The United States Of America, As Represented By The Department Of Health & Human Services Methods of treating established colitis using antibodies against IL-12
AT405235B (de) 1995-11-02 1999-06-25 Helmut Dr Viernstein Probiotisch wirksame formulierung
AUPN698495A0 (en) 1995-12-06 1996-01-04 Pharma Pacific Pty Ltd Improved therapeutic formulation and method
GB2311027B (en) 1996-03-15 1999-10-27 Johnson & Johnson Medical Coated bioabsorbable beads for wound treatment
US5766520A (en) * 1996-07-15 1998-06-16 Universal Preservation Technologies, Inc. Preservation by foam formation
US5660790A (en) * 1996-08-13 1997-08-26 Litmus Concepts, Inc. PH and amine test elements
ATE355360T1 (de) 1996-11-29 2006-03-15 Bio K & Internat Inc Milchsaüreferment das ein spezieller stamm von lactobacillus acidophilus enthältund verwendung
WO1998027967A1 (en) 1996-12-20 1998-07-02 Dumex-Alpharma A/S Release-controlled coated tablets
US5952033A (en) 1996-12-24 1999-09-14 Nestec S.A. Gelatinized cereal product containing oligosaccharide and processes of preparing and using same
DE29724816U1 (de) 1997-01-09 2004-07-22 Société des Produits Nestlé S.A. Probiotik enthaltendes Getreideprodukt
JP4743925B2 (ja) 1997-02-11 2011-08-10 エンタープライズ アイルランド トレーディング アズ バイオリサーチ アイルランド ラクトバシラス・サリバリウス由来の生体に有益な菌株及びそれより得られた抗菌剤
AU2809899A (en) 1997-03-18 1999-07-22 Mendel Institute For Nutraceutical Research Inc, The Dosing beverage with a bacteria formulation
US6133323A (en) * 1997-04-09 2000-10-17 The Iams Company Process for enhancing immune response in animals using β-carotene as a dietary supplement
ES2255730T3 (es) 1997-04-18 2006-07-01 Ganeden Biotech, Inc. Utilizacion topica de esporas de bacilos probioticos para prevenir o tratar las infecciones microbianas.
EP0986314B1 (en) 1997-06-03 2008-09-10 Ganeden Biotech, Inc. Probiotic lactic acid bacterium to treat bacterial infections associated with sids
IT1292636B1 (it) 1997-06-20 1999-02-08 Ascor Chimici Srl Composizione a rilascio controllato di sostanze biologicamente attive ad uso zootecnico.
RU2123343C1 (ru) 1997-06-26 1998-12-20 Алин Борис Иннокентьевич Способ получения капсул, содержащих бактерии b.bifidum (бифидумбактерин сухой в капсулах)
US5976579A (en) * 1997-07-03 1999-11-02 Mclean; Linsey Nutritional supplement for the prevention and treatment of excessive intestinal permeability
FI108512B (fi) 1997-08-22 2002-02-15 Danisco Finland Oy Tahnamainen nautittavaksi tarkoitettu koostumus, sen käyttö ja sitä sisältävät tuotteet
NZ503086A (en) 1997-08-29 2002-03-01 Upjohn Co An orally administrable pharmaceutical composition comprising an inner core and two outer layers, which render it substantially free of unpleasant tastes
KR100387245B1 (ko) 1997-10-17 2003-08-19 일양약품주식회사 유산균의안정화를위한미세장용성코팅과립
AR014129A1 (es) 1997-12-17 2001-02-07 Nutrasweet Co Bebida que comprende fundamentalmente un ester n-[n-(3,3-dimetilbutil)-l- alfa-aspartil]-l-fenilamina 1 - metilico, bebida sin alcohol carbonatada,bebida de jugo, bebida envasada caliente y bebida deportiva de bajas calorias.
EP1065936B1 (en) 1998-03-23 2009-08-05 General Mills, Inc. Encapsulation of components into edible products
FI104405B (fi) 1998-03-27 2000-01-31 Valtion Teknillinen Mikro-organismeja sisältävät tärkkelyskapselit ja niiden valmistusmenetelmä
US5932258A (en) 1998-04-06 1999-08-03 The Iams Company Composition and process for improving glucose metabolism in companion animals
ES2165139T3 (es) 1998-04-30 2002-03-01 Vesely Renata Maria Cavaliere Composiciones farmaceuticas que contienen lactobacillus brevis y lactobacillus salivarius para el tratamiento de infecciones vaginales.
DE19819475A1 (de) 1998-04-30 1999-11-04 Basf Ag Trockene Mikroorganismen-Kulturen und Verfahren zu deren Herstellung
AU4549699A (en) 1998-07-30 2000-02-21 Warner-Lambert Company Centerfill delivery system for nutraceuticals
SE9803871D0 (sv) 1998-11-11 1998-11-11 Pharmacia & Upjohn Ab Therapeutic method and formulation
IT1304170B1 (it) 1998-12-15 2001-03-08 Novartis Nutrition Ag Composti organici
JP2000191519A (ja) 1998-12-25 2000-07-11 Nippon Kayaku Co Ltd 薬効成分の不快な官能的性質が隠蔽された速放性粒状物
DE19860375A1 (de) 1998-12-28 2000-07-06 Aventis Res & Tech Gmbh & Co Alpha Amylase-resistente Stärke zur Herstellung von Nahrungs- und Arzneimittel
ID29150A (id) * 1999-01-15 2001-08-02 Entpr Ireland Cs Penggunaan lactobacillus salivarius
US6692779B2 (en) 1999-03-26 2004-02-17 The Pillsbury Company Food products with biocontrol preservation
ATE301937T1 (de) * 1999-05-27 2005-09-15 Iams Company Verfahren zur herstellung eines produkts zur erhöhung der immunantwort bei haustieren mit verwendung einer kombination von antioxidantien
DE19937361A1 (de) 1999-08-12 2001-02-22 Merck Patent Gmbh Orale Darreichungsform
CA2409286C (en) * 2000-05-25 2012-05-15 Societe Des Produits Nestle S.A. Dog & cat food compositions having a probiotic lactobacillus strain
US6571229B1 (en) 2000-05-31 2003-05-27 Motorola, Inc. Method and apparatus for inerative training of a classification system
WO2002016554A1 (fr) 2000-08-25 2002-02-28 Wakamoto Pharmaceutical Co.,Ltd. Produits probiotiques contenant une bacterie de l'acide lactique
CA2359812C (en) * 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
NZ527930A (en) * 2001-03-16 2005-11-25 Andrx Pharmaceuticals Llc Controlled release sulfonylurea formulation
EP1373475A2 (en) 2001-04-02 2004-01-02 Alimentary Health Limited Immunotherapy based on dendritic cells
PE20030283A1 (es) 2001-07-26 2003-05-01 Alimentary Health Ltd Cepas de lactobacillus casei
PE20030274A1 (es) * 2001-07-26 2003-05-08 Alimentary Health Ltd Cepas de lactobacillus salivarius
US20030092163A1 (en) * 2001-07-26 2003-05-15 Collins John Kevin Probiotic bifidobacterium strains
ATE389389T1 (de) 2001-11-23 2008-04-15 Procter & Gamble Mehrfach beschichete pharmazeutische dosierungsform
US7122370B2 (en) * 2003-01-14 2006-10-17 Randolph Stanley Porubcan Formulations to increase in vivo survival of probiotic bacteria and extend their shelf-life
US8877178B2 (en) * 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050152884A1 (en) 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US7785635B1 (en) * 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US8894991B2 (en) * 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US20050158294A1 (en) * 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum

Also Published As

Publication number Publication date
CA2550307A1 (en) 2005-07-14
US8840880B2 (en) 2014-09-23
EP1718265A2 (en) 2006-11-08
CA2550307C (en) 2014-01-21
AU2004308395B2 (en) 2009-04-23
ES2388739T3 (es) 2012-10-18
US20090169515A1 (en) 2009-07-02
US20090010893A1 (en) 2009-01-08
AU2004308395A1 (en) 2005-07-14
JP4607124B2 (ja) 2011-01-05
AR047294A1 (es) 2006-01-11
JP2007523634A (ja) 2007-08-23
US20090148409A1 (en) 2009-06-11
BRPI0417793B1 (pt) 2016-05-10
US20050152884A1 (en) 2005-07-14
WO2005062878A2 (en) 2005-07-14
EP1718265B1 (en) 2012-06-06
US8900569B2 (en) 2014-12-02
US8809035B2 (en) 2014-08-19
EP1718265A4 (en) 2009-04-29
WO2005062878A3 (en) 2007-12-06

Similar Documents

Publication Publication Date Title
BRPI0417826A (pt) bifidobactéria pseudolongum probiótica canina
BRPI0417793A (pt) bifidobactéria globosum probiótica canina
BRPI0417805A (pt) lactobacilli probióticos caninos
BR0315209A (pt) Formulações nutritivas que contêm substâncias simbióticas
PL1874917T3 (pl) Kompozycja probiotyczna odpowiednia dla zwierząt
BRPI0612298A8 (pt) Aditivo probiótico de alimento, ração e/ou água potável contendo uma mistura de microorganismos destinado à administração em animais e uso deste aditivo como promotor de desempenho e saúde
AU2006253006A8 (en) Feline probiotic Lactobacilli
WO2007117639A3 (en) Synthesis of tetracyclines and analogues thereof
AU2003212265A1 (en) Dietetic and/or pharmaceutical compositions for human and/or animal use based on probiotic microbial preparations
DK1978821T3 (da) Fremgangsmåde til at modificere tarmflora i dyr
ATE534396T1 (de) Probiotische mikroorganismen zur verbesserung der muskulären funktion
BR0111275A (pt) Probióticos para aplicações de alimentos para animais de estimação
CY1107671T1 (el) Νεα συνθεση γαλακτοολιγοσακχαριτη και η παρασκευη της
DE60237645D1 (de) Immunstimulierendes Mittel enthaltend eine Biomasse von methanotrophem Bakterium
BR0314511A (pt) Seleção e uso de bactérias de ácido lático para reduzir a inflamação causada por helicobater
DK1624762T3 (da) Probiotisk præparat med mindst to mælkesyrebakteriestammer som er i stand til kolonisere mavetarmkanalen, i kombination med at de besidder overlevelsesegenskab, tarmbindende egenskab, en infektionsbeskyttelsesegenskab og en fiberfermenterende egenskab
WO2000007606A3 (en) Methods for increasing the solubility of nutritional materials using probiotic lactic acid-producing bacteria
BRPI0407176A (pt) Cepas de bifidobacterium possuindo a capacidade de produzir glutamina
RU2005104060A (ru) Способ профилактики микотоксикозов животных
RU2001135343A (ru) Штамм бактерий Bifidobacterium longum 58B для приготовления биологически активных добавок, регулирующих микрофлору кишечника у детей раннего возраста
RU2001135344A (ru) Штамм бактерий Lactobacillus rhamnosus 12L для приготовления биологически активных добавок, регулирующих микрофлору кишечника у детей раннего возраста
RU2004100068A (ru) Штамм бактерий streptococcus pyogenes n289 для приготовления вакцин против стрептококкоза пушных зверей
ITMI20041232A1 (it) Composizione nutraceutica contenente un numero elevato di fermenti lattici utile come sinbiotico
RU2002118758A (ru) Штамм энтерококков Enterococcus faecium L-3 для изготовления лечебно-профилактических средств и продуктов питания лечебно-профилактического назначения
RU2001135347A (ru) Штамм бактерий Lactobacillus acidophilus 27L для приготовления биологически активных добавок, регулирующих микрофлору кишечника у детей раннего возраста

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25G Requested change of headquarter approved

Owner name: THE IAMS COMPANY (US) , ALIMENTARY HEALTH LTD. (IE

Free format text: ENDERECO DO 1O DEPOSITANTE ALTERADO CONFORME SOLICITADO NA PETICAO NO 020110091535/RJ DE 02/09/2011.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 10/05/2016, OBSERVADAS AS CONDICOES LEGAIS.

B25A Requested transfer of rights approved